6 largecap stocks from different sectors with right ROE and upside potential of up to 24%: At a time when it is not possible to find stocks that can be called "fairly valued" and forget "undervalued”, but the sentiment continues to be bullish, it is tough for retail investors to control their desire to buy stocks. The fact is that this market has been in an overvalued zone for quite some time, but as they say, liquidity and sentiment can ensure that market remains in that zone for longer than anyone expects. So, for investors, it would be wise to take exposure to stocks, where a sector the overall market size is very big or the sector. In the case of pharma, there are some segments in which Indian companies have been able to make a presence, but they do face competition from many other equally well established global pharma companies. But still the Indian companies have an advantage due to skilled manpower at much lower cost which ensures that in the generic segment Indian companies have been to face headwinds and still show growth. So, we look at pharma stocks which are slightly defensive in nature, with stable growth and the biggest reason continues growth in the overall global market. Another sector which is domestically focused is asset management, part of the financial service industry. If one looks at the financialization of savings and the way money has been flowing to mutual funds, over a period of time the growth is bound to come in this part of industry. One of the companies is from the telecom sector, while it has been facing headwinds but given the structure of the industry, it provides basic service to the sector and hence has an element of annuity income which over a period of time will take care of growth in overgrowth. One company is from defence where the tailwinds are well known and expected to continue with continuity in policy focus. Large Cap Stocks with Net Margin & RoE Jan 28, 2024 Company Indus Towers Name Avg 6 Score Reco Hold Analyst 18 Count Upside 24.2 Potential Net 19.8 Margin% ROE 248 Inst 17.4 Stake% 3M 29.4 Returns Market 60,744 Cap Rs Company 360 One Wam Name Avg 6 Score Reco Strong Buy Analyst 7 Count Upside 22.2 Potential Net 35.5 Margin RoE% 22.1 Inst 58.9 Stake 3M 19.5 Returns S Market 22,617 Cap Rs Cr Company Mazagon Dock Shipbuilders Name Avg 7 Score Reco Hold Analyst 3 Count Upside 20.0 Potential Net 16.8 Margin % RoE% 27.3 Inst 1.5 Stake 3M 26.3 Returns Market 47,340 Cap Re Cr Company HDFC AMC Name Avg 8 Score Reco Buy Analyst 20 Count Upside 17.0 Potential Net Margin 73.2 RoE 29.2 Inst 27.7 Stake 3M Returns 21.9 Market 73,197 Cap Rs Cr Company Torrent Pharma Name Avg Score Reco Buy Analyst 31 Count Upside 15.6 Potential Net 151 Margin RoE% 21.0 Inst Stake 13.4 3M 28.7 Returmo Market 83,740 Cap Rs Cr Company Nippon Life india AMC Name Avg Score 7 Reco Buy Analyst 15 Count Upside 8.4 Potential Net Margin % 55.5 25.6 ROE Inst 89.6 Stake 3M 43.4 Returns Market 32,372 source: et
Jan 29 2024, 08:24